2017 HCHB_digital

More documents

Recommendations

Info

PharmacyToday A part of your everyday Working together to keep you up-to-date with pharmacy news, views, commentary, clinical developmentsandeducation. SUBSCRIBE • Latest pharmacy headlines • Online learning • Hot retail tips • Prizes & giveaways • Healthcare Handbook 09 488 4286 www.pharmacytoday.co.nz
Medicines Safety The New Zealand Pharmacovigilance Centre (NZPhvC) is the main body in New Zealand responsible for monitoring the safety of medicines and related products in New Zealand through voluntary reporting of adverse events. The NZPhvC oversees the Centre for Adverse Reactions Monitoring (CARM), the Medication Error Reporting Programme (MERP) and the Psychoactive Substances, Recreational Substances & Legal Highs reporting programme. Adverse Reactions Monitoring CARM collects and evaluates spontaneous reports of adverse reactions to medicines, vaccines, herbal products and dietary supplements sent in by health professionals, patients and pharmaceutical companies throughout New Zealand. These reports are routinely shared with Medsafe. Over 110,000 reports are currently held by the CARM database providing New Zealand-specific information that can help contribute to knowledge already known about the adverse reaction profiles of certain medicines or complementary therapies. This knowledge can help support clinical decision making. CARM also undertakes regular analysis of the database to identify any significant patterns of adverse reactions. These results may be considered by the Medicines Adverse Reactions Committee who may suggest to Medsafe that relevant prescribing advice for a particular product be emphasised or changed. This should result in the safer use of the medicine concerned. Information collected by CARM and other international monitoring centres is fed into the World Health Organization’s International Drug Monitoring Programme database, based in Uppsala, Sweden. This allows New Zealand and other countries to keep abreast of the latest concerns around drug safety as they emerge. New Zealand is the third highest reporting country globally, behind Singapore and the United States of America. What to report It is important to report any suspect reactions of clinical concern. This includes adverse reactions or interactions to all: •• medicines •• vaccines •• over the counter remedies or medicines •• herbal, traditional and alternative remedies. Reactions and interactions that are serious and medically significant should always be reported; however, if you are unsure of its significance, report it! It is also important to report ANY serious allergic reactions so that a danger warning can be entered against the patient’s name in the national health database, so re-exposure can be avoided for that individual. How to report Anybody can report an adverse event. An online reporting form is available on the NZ Pharmacovigilance Centre website (nzphvc.otago.ac.nz). A link to this site is also available through Medsafe (www.medsafe.govt.nz/profs/adverse/ reactions.asp). Alternatively, reports can be made to CARM by telephone (03 479 7247) or by downloading the ADR Reporting Card from nzphvc. otago.ac.nz/reporting-forms. Once completed, these can be either faxed (03 479 7150), emailed (nzphvc@otago.ac.nz), or posted back to: NZPhvC University of Otago Medical School PO Box 913 Dunedin 9054 NEW ZEALAND Medication Error Reporting Programme (MERP) MERP collects and analyses voluntary reports from healthcare professionals of actual and ‘near miss’ medication errors occurring in primary care. Its aim is to enhance the safety of medication use for New Zealanders by sharing information about medication errors to reduce and prevent other harmful medication errors. An online reporting form for MERP is available on the NZ Pharmacovigilance Centre website (nzphvc.otago.ac.nz/merp/report/). Psychoactive Substances, Recreational Substances & Legal Highs This programme aims to provide a way for health professionals and members of the public to report reactions to psychoactive substances. The programme was developed by CARM in response to a request by the Psychoactive Substances team at the Ministry of Health. Each individual report is anonymised for both patient and reporter and findings are used by the Ministry of Health as part of their ongoing safety review of products that are under review in terms of the Psychoactive Substances Act. An online reporting form is available on the NZ Pharmacovigilance Centre website (nzphvc.otago.ac.nz/substance/). The online form also links to a gallery of images of currently known psychoactive substances, which can be used to help identify the substance of concern. M 2 Medicines monitoring scheme M 2 is a medicines monitoring scheme which aims to: • • highlight safety concerns identified from reports of suspected adverse medicine reactions sent to CARM • • encourage further reports and increase the information on these potential safety concerns. This helps CARM and Medsafe to investigate these safety concerns and decide if any action needs to be taken. It is important to note that the appearance of a possible safety issue to a medicine does not mean that Medsafe and CARM have concluded that this medicine causes the reaction. Current medicines with safety concerns on the M 2 list at the time of going to print were: • • Viekira Pak and Viekira Pak-RBV – possible effects on blood glucose control when used in people with type 2 diabetes • • iodine-containing contrast agents – possible risk of hypothyroidism in infants exposed to these agents • • rivaroxaban, dabigatran, apixaban – possible risk of alopecia (hair loss). Medicines remain on the M 2 list for approximately six months and the list of medicines being monitored changes regularly. For more information see www. medsafe.govt.nz/safety/EWS/monitoring-communications.asp Page 183
Page 1 and 2:
HEALTHCARE HANDBOOK incorporating t
Page 3 and 4:
2017-2018 HEALTHCARE HANDBOOK PUBLI
Page 5 and 6:
Index Common Disorders Acne--------
Page 7 and 8:
Asthma and COPD CONTINUING OTC EDUC
Page 9 and 10:
Head and scalp • Condition of hai
Page 11 and 12:
HELP KIDS BE THEMSELVES AGAIN NEW L
Page 14 and 15:
NUROFEN ZAVANCE* IS ABSORBED UP TO
Page 16 and 17:
Acne Acne is a common skin problem
Page 18 and 19:
Allergies An allergy occurs when th
Page 20 and 21:
Asthma and COPD Asthma New Zealand
Page 22 and 23:
Baby Feeding Breastfeeding is best
Page 24 and 25:
Bites and Stings Bites and stings c
Page 26 and 27:
Bruises, Scars, Spider Veins Bruise
Page 28 and 29:
Childhood Diseases and Immunisation
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Childhood Pain and Baby Teething Pa
Page 38 and 39:
Colds A cold is a contagious viral
Page 40 and 41:
Cold Sores Cold sores are fluid-fil
Page 42 and 43:
Constipation Constipation is the te
Page 44 and 45:
Contraception & Sexual Wellbeing Co
Page 46 and 47:
Contraception: Emergency Emergency
Page 48 and 49:
Coughs: Dry Coughs are called dry o
Page 50 and 51:
Coughs: Productive Coughs are consi
Page 52 and 53:
Cuts, Abrasions and Blisters This t
Page 54 and 55:
Cystitis [Bladder Infection] Cystit
Page 56 and 57:
Dandruff Dandruff is a common condi
Page 58 and 59:
Dermatitis/Eczema Dermatitis is a g
Page 60 and 61:
Diabetes Diabetes is a condition in
Page 62 and 63:
Diarrhoea and Vomiting Diarrhoea an
Page 64 and 65:
Dry Skin Dry skin is skin that lack
Page 66 and 67:
Ear Conditions Our ears allow us to
Page 68 and 69:
Eye Conditions Almost two-thirds of
Page 70 and 71:
Eye Conditions (continued) Type Sym
Page 72 and 73:
Eyes: Contact Lenses Contact lenses
Page 74 and 75:
Fever What is fever Fever is define
Page 76 and 77:
Foot Care Common foot problems incl
Page 78 and 79:
Fungal Infections: Superficial Supe
Page 80 and 81:
Fungal Nail Infections (Onychomycos
Page 82 and 83:
Gout Historically known as the “d
Page 84 and 85:
Haemorrhoids Haemorrhoids (also cal
Page 86 and 87:
Hair Loss Alopecia is the medical t
Page 88 and 89:
Hay Fever Hay fever (also called in
Page 90 and 91:
Hay Fever (continued) TREATMENT OPT
Page 92 and 93:
Headache Headaches are common and c
Page 94 and 95:
Head Lice Head lice (pediculosis ca
Page 96 and 97:
Heart Health Cardiovascular (CV) di
Page 98 and 99:
Indigestion, Heartburn and Gastriti
Page 100 and 101:
Influenza Influenza (flu) is a comm
Page 102 and 103:
Influenza (continued) TREATMENT OPT
Page 104 and 105:
Iron Deficiency Iron is an essentia
Page 106 and 107:
Irritable Bowel Syndrome Irritable
Page 108 and 109:
Menopause Menopause - the “change
Page 110 and 111:
Migraine Migraines are a type of se
Page 112 and 113:
Muscular Aches, Pains and Tightness
Page 114 and 115:
Nappy Rash Nappy rash is a red rash
Page 116 and 117:
Oral Health Oral health disorders i
Page 118 and 119:
Osteoarthritis Osteoarthritis is th
Page 120 and 121:
Osteoporosis Osteoporosis (meaning
Page 122 and 123:
Period Pain and Endometriosis Perio
Page 124 and 125:
Poisonings Any substance that has t
Page 126 and 127:
Pregnancy Tests and Supplements Hom
Page 128 and 129:
Preventive Health There are certain
Page 130 and 131:
Probiotics and Prebiotics Probiotic
Page 132 and 133:
Psoriasis Psoriasis is a long-term
Page 134 and 135:
Scabies Scabies is a very contagiou
Page 136 and 137:
Shingles Shingles (herpes zoster) i
Page 138 and 139: Sinus and Nasal Problems Sinuses ar
Page 140 and 141: Sleep Problems and Snoring Sleep is
Page 142 and 143: Smoking Cessation Almost 5000 New Z
Page 144 and 145: Sore Throat Sore throats are very c
Page 146 and 147: Strains and Sprains Sprains and str
Page 148 and 149: Sun Care Sunburn Sunburn occurs fro
Page 150 and 151: Sun Care: Eye Protection Protecting
Page 152 and 153: Sweating: Excessive (Hyperhidrosis)
Page 154 and 155: Toothache Toothache is the term use
Page 156 and 157: Travel Health (including Vaccinatio
Page 158 and 159: Travel Sickness Travel, or motion,
Page 160 and 161: Urinary Incontinence Urinary incont
Page 162 and 163: Urticaria (Hives) Urticaria refers
Page 164 and 165: Vaginal Health The vagina is a clos
Page 166 and 167: Varicose Veins and Support Stocking
Page 168 and 169: Vitamins and Dietary Supplements Vi
Page 170 and 171: Warts Warts are benign (non-cancero
Page 172 and 173: Weight Loss Obesity has reached epi
Page 174 and 175: Worms Pinworms (Enterobius vermicul
Page 176 and 177: Wound Care Our skin acts as a barri
Page 178 and 179: Wound Care (continued) Wound type M
Page 180 and 181: Glossary WHAT DOES THAT WORD MEAN?
Page 182 and 183: Chapter References (continued) Diar
Page 184 and 185: Chapter References (continued) Gord
Page 186 and 187: Significant learning opportunity: W
Page 190 and 191: OTC Medicines: Interactions When se
Page 192 and 193: OTC Medicines: Interactions OTC Med
Page 198 and 199: OTC Medicines: Precautions OTC Medi
Page 200 and 201: OTC Medicines: Precautions OTC Medi
Page 202 and 203: OTC Medicines: Adverse Effects OTC
Page 204 and 205: Herbal Supplements: Interactions He
Page 212 and 213: Drugs in Sport Treating Athletes Me
Page 214 and 215: Drugs in Aviation AVIATION - PRECAU
Page 216 and 217: Drugs in Pregnancy Drug use in preg
Page 218 and 219: NZ Support Groups ADHD Association
Page 220 and 221: NZ Support Groups New Zealand AIDS
Page 222 and 223: HEAT or INFLAMMATION Unlike heat ru
Page 224 and 225: OTC Products Over-the-counter produ
Page 226 and 227: OTC Products Index Foot Care - Fung
Page 228 and 229: »» Acne CRYSTADERM CREAM AFT PHAR
Page 230 and 231: »» Childhood Pain and Baby Teethi
Page 232 and 233: »» Colds BONNINGTON’S IRISH MOS
Page 234 and 235: CODRAL RELIEF MAX STRENGTH COLD & F
Page 236 and 237: OTRIVIN JUNIOR GLAXOSMITHKLINE CONS
Page 238 and 239:
DULCOLAX SANOFI CONSUMER HEALTHCARE
Page 240 and 241:
BENADRYL MUCUS RELIEF DOUBLE ACTION
Page 242 and 243:
»» Dandruff COCO-SCALP AFT PHARMA
Page 244 and 245:
EAR CLEAR WILSON CONSUMER PRODUCTS
Page 246 and 247:
»» Foot Care - Fungal Infections
Page 248 and 249:
TELFAST ORAL LIQUID SANOFI CONSUMER
Page 250 and 251:
NUROFEN ZAVANCE RECKITT BENCKISER (
Page 252 and 253:
MOOV HEAD LICE SOLUTION DOUGLAS PHA
Page 254 and 255:
GAVISCON DUAL ACTION LIQUID RECKITT
Page 256 and 257:
CODRAL COLD & FLU + COUGH JOHNSON &
Page 258 and 259:
»» Irritable Bowel Syndrome GASTR
Page 260 and 261:
VOLTAREN EMULGEL GLAXOSMITHKLINE CO
Page 262 and 263:
TURMERIC EXTRA STRENGTH GOOD HEALTH
Page 264 and 265:
PREGNOSIS EARLY PREGNANCY TEST DIP
Page 266 and 267:
»» Sexual Wellbeing - Contracepti
Page 268 and 269:
SUDAFED PE SINUS DAY + NIGHT RELIEF
Page 270 and 271:
NICORETTE INHALATOR JOHNSON & JOHNS
Page 272 and 273:
STREPSILS PLUS LOZENGES RECKITT BEN
Page 274 and 275:
TRAVACALM TRAVEL BAND WILSON CONSUM
Page 276 and 277:
CRYSTADERM CREAM AFT PHARMACEUTICAL
Page 278 and 279:
An ENHANCED ELearning Experience As
Page 280 and 281:
Product Index ANIME LUBRICANT 50ML-
Page 282 and 283:
Manufacturer’s Index AFT Pharmace
Page 284:
Topiramate Actavis Topiramate 25mg,
show all

2017 HCHB_digital

Create successful ePaper yourself

Delete template?

Save as template?